Pharsight Corporation To Host Webinar On Increasing Productivity Of Pharmacokinetic Analysis

MOUNTAIN VIEW, Calif., May 1 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software and strategic services for optimizing clinical drug development, announced today that Simon Davis, Senior Scientific Consultant, Deployment Services, will speak to members of the pharmaceutical and biotechnology industries at a webinar on tools and techniques for increasing the productivity of PK analysis.

The webinar will be held twice on May 10, 2006, at 10:00 AM Eastern Daylight Time (3:00 PM GMT, 7:00 AM PDT) and again at 3:00 PM Eastern Daylight Time (8:00 PM GMT, 12:00 PM PDT). More information is available at http://www.pharsight.com/events/events_home.php .

“Our aim is to provide productive, compliant end-to-end solutions for PK data management, analysis, and reporting,” said Shawn O’Connor, Pharsight president and CEO. “We believe interest in the productivity of PK analysis is growing as pharmaceutical and biotechnology companies cope with the burden of an expanding early clinical pipeline.”

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company’s goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight’s approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com .

Registered Trademarks and Trademarks

Pharsight(R) is a registered trademark of Pharsight Corporation.

Pharsight Corporation

CONTACT: investors, Douglas Sherk, +1-415-896-6820, or JenniferBeugelmans, +1-415-896-6820, or media, Steve DiMattia, +1-646-277-8706, allof EVC Group, for Pharsight Corporation

MORE ON THIS TOPIC